SuperworthAspire Biopharma shares outstanding ASBP
Diluted shares outstanding, averaged over each quarter, from 2021.
- Latest quarter, to Jun 30, 2026
- 1M
- On a year earlier
- +2424.6%
- more shares
Aspire Biopharma had 1M diluted shares outstanding on average in Q2 FY26, the quarter to Jun 30, 2026.
That is 2424.6% more than a year earlier, so each share owns a little less of the company.
Shares outstanding over time
Fiscal year by fiscal year
| Fiscal year | Shares, fourth quarter | Change |
|---|---|---|
| FY2024 | 6.5K | −14% |
| FY2023 | 7.5K | +25% |
| FY2022 | 6K | n/a |
Each fiscal year is the twelve months to its fourth quarter, shown as the fourth quarter's average share count.
Quarter by quarter
| Quarter | Ended | Shares outstanding | On a year earlier |
|---|---|---|---|
| Q2 FY26 | 1M | +2425% | |
| Q1 FY26 | 156.7K | −100% | |
| Q3 FY25 | 41.3K | +79% | |
| Q2 FY25 | 41.1K | +79% | |
| Q1 FY25 | 31.6M | +137185% | |
| Q4 FY24 | 6.5K | −14% | |
| Q3 FY24 | 23K | +207% | |
| Q2 FY24 | 23K | +74% | |
| Q1 FY24 | 23K | −4% | |
| Q4 FY23 | 7.5K | +25% | |
| Q3 FY23 | 7.5K | −69% | |
| Q2 FY23 | 13.2K | +121% |
What the shares outstanding tells you
Diluted shares outstanding, averaged over the period. Fewer shares means each one owns more of the company.
A falling count usually means buybacks. A rising one means stock pay, acquisitions paid in shares or new shares sold.
More on Aspire Biopharma
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.